← Leaderboards
Jaewon Min
Columbia University Health Sciences
$1,399,868
Attributed
$1,399,868
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $411.3K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,399,868 · 2
By mechanism
R35$822,500 · 1
K22$577,368 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Anil K Rustgi$51,275,906
- Ramon E Parsons$25,379,842
- Richard J Baer$14,462,602
- Cory Abate-Shen$42,493,197
- Benjamin Tycko$19,558,566
Others in their field
Other Emerging Leaders on “Telomere”
- Karen Hayden Miga · University Of California Santa Cruz$6,894,118
- Melanie Koenigshoff · University Of Pittsburgh At Pittsburgh$5,239,478
- John Ramunas · Rejuvenation Technologies, Inc.$4,466,431
- Kathryn Edin · Princeton University$4,396,874
- Idan Shalev · University Of Washington$4,047,201
- Jamie Glover · Social And Scientific Systems, Inc.$3,945,237
Research focus
TelomereTelomere MaintenanceDna BiosynthesisTelomeraseCellular BiologyAtp PhosphohydrolaseAlternative TherapiesDiagnosisCluster AnalysisAnti-Cancer TherapeuticBiophysicsApplications GrantsCancer CellCancer Cell LineComplementary DnaCell Culture TechniquesCell Culture SystemAcute Promyelocytic LeukemiaCell LineCellsClinical TrialsCareerCandidate Disease GeneAlternative Treatment
Grant awards (5)
Mechanisms and Genetic Consequences of Break-Induced Replication.$411,250
R35 · FY2025 · GM · contact PI
Mechanisms and Genetic Consequences of Break-Induced Replication.$411,250
R35 · FY2024 · GM · contact PI
Anti-cancer therapeutic approaches for targeting the ALT telomere maintenance mechanism$192,456
K22 · FY2023 · CA · contact PI
Anti-cancer therapeutic approaches for targeting the ALT telomere maintenance mechanism$192,456
K22 · FY2022 · CA · contact PI
Anti-cancer therapeutic approaches for targeting the ALT telomere maintenance mechanism$192,456
K22 · FY2021 · CA · contact PI